Book Chapters
Pett SL; Emery S, 2010, 'Atazanavir', in Grayson ML; Crowe SM; McCarthy JS; Mills J; Mouton JW; Norrby SR; Paterson DL; Pfaller MA (ed.), Kucers' the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs, Hodder Arnold, London, pp. 2830 - 2841
Pett SL; Post JJ, 2009, 'Mycobacterium tuberculosis', in Hoy J; Lewin S; Post JJ; Street A (ed.), HIV Management in Australasia: a guide for clinical care, Australasian Society for HIV Medicine Inc., Darlinghurst, NSW, pp. 149 - 153
Pett SL; Cooper DA, 2008, 'Classification and spectrum', in Mildvan D (ed.), International Atlas of AIDS, 4th ed., Springer, Philadelphia, PA, pp. 77 - 90
Pett SL; Emery S; Cooper DA, 2006, 'Initial treatment of HIV-1 infection. Online access: www.antimicrobe.org', in Singh N; Swindells S; Shafer R (ed.), HIV Clinical Manual, ESun Technologies, LLC, online
Aichelburg A; Pett SL; Cooper DA, 2002, 'AIDS as a World Health Problem', in AIDS as a World Health Problem, MacMillan Publishers, www.els.net, pp. 1 - 6
Aichelburg A; Pett SL; Cooper DA, 2002, 'AIDS: Understanding HIV Transmission', in Encyclopedia of World Sciences, MacMillan Publishers, www.els.net, pp. 1 - 6
Journal articles
Cooke GS; Hung LM; Flower B; McCabe L; Hang VTK; Thu VT; Thuan DT; Dung NT; Phuong LT; Khoa DB; An NTC; Thach PN; Huong VTT; Bich DT; Tuyen NK; Ansari MA; Le Ngoc C; Quang VM; Phuong NTN; Thao LT; Tran NB; Kestelyn E; Kingsley C; Van Doorn R; Rahman M; Pett SL; Thwaites GE; Barnes E; Day JN; Chau NVV; Walker AS, 2025, 'Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial.', Lancet, 405, pp. 1769 - 1780, http://dx.doi.org/10.1016/S0140-6736(25)00097-2
Ottaway Z; Campbell L; Fox J; Burns FM; Hamzah L; Schoeman S; Price D; Clarke A; Pett SL; Onyango D; Sabin C; Miller RF; Post FA; COVID-AFRICA study group , 2025, 'Post-acute sequelae of COVID-19 in people of Black ethnicities living with HIV in the United Kingdom.', Int J STD AIDS, pp. 9564624251334227, http://dx.doi.org/10.1177/09564624251334227
Wood GK; Sargent BF; Ahmad Z-U-A; Tharmaratnam K; Dunai C; Egbe FN; Martin NH; Facer B; Pendered SL; Rogers HC; Hübel C; van Wamelen DJ; Bethlehem RAI; Giunchiglia V; Hellyer PJ; Trender W; Kalsi G; Needham E; Easton A; Jackson TA; Cunningham C; Upthegrove R; Pollak TA; Hotopf M; Solomon T; Pett SL; Shaw PJ; Wood N; Harrison NA; Miller KL; Jezzard P; Williams G; Duff EP; Williams S; Zelaya F; Smith SM; Keller S; Broome M; Kingston N; Husain M; Vincent A; Bradley J; Chinnery P; Menon DK; Aggleton JP; Nicholson TR; Taylor J-P; David AS; Carson A; Bullmore E; Breen G; Hampshire A; COVID-CNS Consortium ; Michael BD; Paddick S-M; Leek EC, 2025, 'Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction.', Nat Med, 31, pp. 245 - 257, http://dx.doi.org/10.1038/s41591-024-03309-8
STRIVE ICOS and PCOS Study Groups , 2025, 'Predictors of hospitalization, death and incomplete/non-recovery from SARS-CoV-2 in an ambulatory global population.', Int J Infect Dis, 151, pp. 107285, http://dx.doi.org/10.1016/j.ijid.2024.107285
Jensen TO; Harper K; Gupta S; Liu ST; Dharan NJ; Baker JV; Pett SL; Shaw-Saliba K; Esmail A; Ho MQ; Almasri E; Dewar RL; Lundgren J; Vock DM, 2024, 'Impact of Baseline SARS-CoV-2 Load in Plasma and Upper Airways on the Incidence of Acute Extrapulmonary Complications of COVID-19: A Multicentric, Prospective, Cohort Study', Clinical Infectious Diseases, 79, pp. 1394 - 1403, http://dx.doi.org/10.1093/cid/ciae469
Griffiths J; Adshead F; Al-Shahi Salman R; Anderson C; Bedson E; Bliss J; Boshoff A; Chen X; Cranley D; Doran P; Dunne F; Gamble C; Gillies K; Hood K; Kavanagh C; Malone J; Mcgregor N; Mcnamara C; Midha E; Moore K; Murphy L; Newman C; O'reilly S; Perkins AM; Pett S; Sydes MR; Whitty L; You F; Fox L; Williamson PR, 2024, 'What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trials', BMJ Open, 14, pp. e088600, http://dx.doi.org/10.1136/bmjopen-2024-088600
de Kretser D; Mora J; Bloomfield M; Campbell A; Cheng MP; Guy S; Hensgens M; Kalimuddin S; Lee TC; Legg A; Mahar RK; Marks M; Marsh J; McGlothin A; Morpeth SC; Sud A; Ten Oever J; Yahav D; Bonten M; Bowen AC; Daneman N; van Hal SJ; Heriot GS; Lewis RJ; Lye DC; McQuilten Z; Paterson DL; Owen Robinson J; Roberts JA; Scarborough M; Webb SA; Whiteway L; Tong SYC; Davis JS; Walls G; Goodman AL; SNAP Early Oral Switch Domain-Specific Working Group and SNAP Global Trial Steering Committee ; SNAP Trial Group , 2024, 'Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol.', Clin Infect Dis, 79, pp. 871 - 887, http://dx.doi.org/10.1093/cid/ciad666
McCabe L; Burns JE; Latifoltojar A; Post FA; Fox J; Pool E; Waters A; Santana B; Garvey L; Johnson M; McGuinness I; Chouhan M; Edwards J; Goodman AL; Cooke G; Murphy C; Collaco-Moraes Y; Webb H; Gregory A; Mohamed F; Rauchenberger M; Ryder SD; Sandford C; Baker JV; Angus B; Boesecke C; Orkin C; Punwani S; Clark A; Gilson R; Dunn D; Pett SL; the MAVMET Study group , 2024, 'MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIV.', AIDS, 38, pp. 1513 - 1522, http://dx.doi.org/10.1097/QAD.0000000000003947
Aggarwal NR; Nordwall J; Braun DL; Chung L; Coslet J; Der T; Eriobu N; Ginde AA; Hayanga AJ; Highbarger H; Holodniy M; Horcajada JP; Jain MK; Kim K; Laverdure S; Lundgren J; Natarajan V; Nguyen HH; Pett SL; Phillips A; Poulakou G; Price DA; Robinson P; Rogers AJ; Sandkovsky U; Shaw-Saliba K; Sturek JM; Trautner BW; Waters M; Reilly C; ACTIV-3/TICO Study Group , 2024, 'Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.', Clin Infect Dis, 78, pp. 1490 - 1503, http://dx.doi.org/10.1093/cid/ciad780
Moore AEB; Burns JE; Sally D; Milinkovic A; Krokos G; John J; Rookyard C; Borca A; Pool ERM; Tostevin A; Harman A; Dulnoan DS; Gilson R; Arenas-Pinto A; Cook GJR; Saunders J; Dunn D; Blake GM; Pett SL, 2024, 'Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV.', AIDS, 38, pp. 521 - 529, http://dx.doi.org/10.1097/QAD.0000000000003811
Scott K; Chappell E; Mostafa A; Volokha A; Najmi N; Ebeid F; Posokhova S; Sikandar R; Vasylyev M; Zulfiqar S; Kaminskyi V; Pett S; Malyuta R; Karpus R; Ayman Y; Ahmed RHM; Hamid S; El-Sayed MH; Gibb D; Judd A; Collins IJ, 2024, 'Acceptability of hepatitis C screening and treatment during pregnancy in pregnant women in Egypt, Pakistan, and Ukraine: A cross-sectional survey.', Clin Liver Dis (Hoboken), 23, pp. e0140, http://dx.doi.org/10.1097/CLD.0000000000000140
Ko S; Dominguez-Dominguez L; Ottaway Z; Campbell L; Fox J; Burns F; Hamzah L; Ustianowski A; Clarke A; Kegg S; Schoeman S; Jones R; Pett SL; Hudson J; Post FA, 2024, 'Cardiovascular disease risk in people of African ancestry with HIV in the United Kingdom.', HIV Med, 25, pp. 1289 - 1297, http://dx.doi.org/10.1111/hiv.13706
Hachicha-Maalej N; Collins IJ; Ades AE; Scott K; Judd A; Mostafa A; Chappell E; Hamdy-El-Sayed M; Gibb D; Pett S; Mariné-Barjoan E; Volokha A; Yazdanpanah Y; Deuffic-Burban S, 2024, 'Corrigendum to "Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine" [J Hepatol (2023) 937-946].', J Hepatol, 80, pp. 379, http://dx.doi.org/10.1016/j.jhep.2023.12.013
Arenas-Pinto A; Bakewell N; Milinkovic A; Williams I; Vera J; Post FA; Anderson J; Beynon M; O'Brien A; Doyle N; Gilson R; Pett SL; Winston A; Sabin CA; Pharmacokinetic and clinical Observations in People over fiftY [POPPY]) study , 2024, 'Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohort.', HIV Med, 25, pp. 95 - 106, http://dx.doi.org/10.1111/hiv.13540
Hachicha-Maalej N; Lepers C; Collins IJ; Mostafa A; Ades AE; Judd A; Scott K; Gibb DM; Pett S; Indolfi G; Yazdanpanah Y; El Sayed MH; Deuffic-Burban S, 2024, 'Modelling the potential clinical and economic impact of universal antenatal hepatitis C (HCV) screening and providing treatment for pregnant women with HCV and their infants in Egypt: a cost-effectiveness study.', BMJ Public Health, 2, pp. e000517, http://dx.doi.org/10.1136/bmjph-2023-000517
AMR-X Collaborators , 2024, 'System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework.', Lancet Microbe, 5, pp. e500 - e507, http://dx.doi.org/10.1016/S2666-5247(24)00003-X
Anagnostou N; Archuleta S; Athan E; Barina L; Best E; Bloomfield M; Bostock J; Botheras C; Bowen A; Britton P; Burden H; Campbell A; Carter H; Cheng M; Chew KL; Chong IRLM; Coombs G; Daley P; Daneman N; Davies J; Davis J; Dishon-Benattar Y; Dotel R; Dunlop A; Flack F; Flanagan K; Foo H; Ghanem-Zoubi N; Giulieri S; Goodman A; Grant J; Gregson D; Guy S; Gwee A; Hardy E; Henderson A; Heriot G; Howden B; Hudson F; Johnstone J; Kalimuddin S; de Kretser D; Kwa A; Lee T; Legg A; Lewis R; Llewelyn M; Lumley T; Lye D; MacFadden D; Mahar R; Malhame I; Marks M; Marsh J; Martinello M; Matthews G; McArthur C; McGlothlin A; McKew G; McMullan B; McQuilten Z; Milliken E; Mora J; Morpeth S; Murthy S; Nourse C; O'Sullivan M; Paterson D; Paul M; Petersiel N; Petrella L; Pett S; Price D; Roberts J; Robinson JO; Rogers B; Saville B; Scarborough M; Scheetz M; Scheuerman O; Schwartz K; Smith S; Snelling T; Soares M; Sommerville C; Stewardson A; Stone N; Sud A; Tilley R; Tong S; Turner R; Underwood J; van Hal S; Voss L; Walls G; Webb R; Webb S; Whiteway L; Wilson H; Wuerz T; Yahav D, 2023, 'The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe (vol 75, pg 2027, 2022)', CLINICAL INFECTIOUS DISEASES, http://dx.doi.org/10.1093/cid/ciac730
Flower B; Hung LM; Mccabe L; Ansari MA; Le Ngoc C; Vo Thi T; Vu Thi Kim H; Nguyen Thi Ngoc P; Phuong LT; Quang VM; Dang Trong T; Le Thi T; Nguyen Bao T; Kingsley C; Smith D; Hoglund RM; Tarning J; Kestelyn E; Pett SL; van Doorn R; Van Nuil JI; Turner H; Thwaites GE; Barnes E; Rahman M; Walker AS; Day JN; Chau NVV; Cooke GS, 2023, 'Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study.', Elife, 12, http://dx.doi.org/10.7554/eLife.81801
Grundmann A; Wu C-H; Hardwick M; Baillie JK; Openshaw PJM; Semple MG; Böhning D; Pett S; Michael BD; Thomas RH; Galea I; ISARIC4C investigators , 2023, 'Fewer COVID-19 Neurological Complications with Dexamethasone and Remdesivir.', Ann Neurol, 93, pp. 88 - 102, http://dx.doi.org/10.1002/ana.26536
Hachicha-Maalej N; Collins IJ; Ades AE; Scott K; Judd A; Mostafa A; Chappell E; Hamdy-El-Sayed M; Gibb D; Pett S; Mariné-Barjoan E; Volokha A; Yazdanpanah Y; Deuffic-Burban S, 2023, 'Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine.', J Hepatol, 78, pp. 937 - 946, http://dx.doi.org/10.1016/j.jhep.2022.12.032
Sy A; McCabe L; Hudson E; Ansari AM; Pedergnana V; Lin S-K; Santana S; Fiorino M; Ala A; Stone B; Smith M; Nelson M; Barclay ST; McPherson S; Ryder SD; Collier J; Barnes E; Walker AS; Pett SL; Cooke G; STOP-HCV-1 trial team , 2023, 'Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus.', PLoS One, 18, pp. e0280551, http://dx.doi.org/10.1371/journal.pone.0280551
Rogers AJ; Wentworth D; Phillips A; Shaw-Saliba K; Dewar RL; Aggarwal NR; Babiker AG; Chang W; Dharan NJ; Davey VJ; Higgs ES; Gerry N; Ginde AA; Hayanga JWA; Highbarger H; Highbarger JL; Jain MK; Kan V; Kim K; Lallemand P; Leshnower BG; Lutaakome JK; Matthews G; Mourad A; Mylonakis E; Natarajan V; Padilla ML; Pandit LM; Paredes R; Pett S; Ramachandruni S; Rehman MT; Sherman BT; Files DC; Brown SM; Matthay MA; Thompson BT; Neaton JD; Lane HC; Lundgren JD, 2022, 'The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19', Annals of Internal Medicine, 175, pp. 1401 - 1410, http://dx.doi.org/10.7326/M22-0924
Holland TL; Ginde AA; Paredes R; Murray TA; Engen N; Grandits G; Vekstein A; Ivey N; Mourad A; Sandkovsky U; Gottlieb RL; Berhe M; Jain MK; Marines-Price R; Agbor Agbor BT; Mateu L; España-Cueto S; Lladós G; Mylonakis E; Rogers R; Shehadeh F; Filbin MR; Hibbert KA; Kim K; Tran T; Morris PE; Cassity EP; Trautner B; Pandit LM; Knowlton KU; Leither L; Matthay MA; Rogers AJ; Drake W; Jones B; Poulakou G; Syrigos KN; Fernández-Cruz E; Natale MD; Almasri E; Balerdi-Sarasola L; Bhagani SR; Boyle KL; Casey JD; Chen P; Douin DJ; Files DC; Günthard HF; Hite RD; Hyzy RC; Khan A; Kibirige M; Kidega R; Kiweewa F; Jensen JU; Leshnower BG; Lutaakome JK; Manian P; Menon V; Morales-Rull JL; O'Mahony DS; Overcash JS; Ramachandruni S; Steingrub JS; Taha HS; Waters M; Young BE; Phillips AN; Murray DD; Jensen TO; Padilla ML; Sahner D; Shaw-Saliba K; Dewar RL; Teitelbaum M; Natarajan V; Rehman MT; Pett S; Hudson F; Touloumi G; Brown SM; Self WH; Chang CC; Sánchez A; Weintrob AC; Hatlen T; Grund B; Sharma S; Reilly CS; Garbes P; Esser MT; Templeton A; Babiker AG; Davey VJ; Gelijns AC; Higgs ES; Kan V; Matthews G; Thompson BT; Neaton JD, 2022, 'Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial', Lancet Respiratory Medicine, 10, pp. 972 - 984, http://dx.doi.org/10.1016/S2213-2600(22)00215-6
Douin DJ; Siegel L; Grandits G; Phillips A; Aggarwal NR; Baker J; Brown SM; Chang CC; Goodman AL; Grund B; Higgs ES; Hough CL; Murray DD; Paredes R; Parmar M; Pett S; Polizzotto MN; Sandkovsky U; Self WH; Young BE; Babiker AG; Davey VJ; Kan V; Gelijns AC; Matthews G; Thompson BT; Lane HC; Neaton JD; Lundgren JD; Ginde AA; Meintjes GA; Armstrong W; Glidden D; Maldonado Y; Murray BE; Ray SC; Rolla VC; Saloojee H; Tsiatis AA; Volberding PA; Kimmelman J; Hunsberger S, 2022, 'Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery', American Journal of Respiratory and Critical Care Medicine, 206, pp. 730 - 739, http://dx.doi.org/10.1164/rccm.202112-2836OC
Mylonakis E, 2022, 'Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 A Randomized Controlled Trial', Annals of Internal Medicine, 175, pp. 1266 - 1274, http://dx.doi.org/10.7326/M22-1503
Self WH; Sandkovsky U; Reilly CS; Vock DM; Gottlieb RL; Mack M; Golden K; Dishner E; Vekstein A; Ko ER; Der T; Franzone J; Almasri E; Fayed M; Filbin MR; Hibbert KA; Rice TW; Casey JD; Hayanga JA; Badhwar V; Leshnower BG; Sharifpour M; Knowlton KU; Peltan ID; Bakowska E; Kowalska J; Bowdish ME; Sturek JM; Rogers AJ; Files DC; Mosier JM; Gong MN; Douin DJ; Hite RD; Trautner BW; Jain MK; Gardner EM; Khan A; Jensen JU; Matthay MA; Ginde AA; Brown SM; Higgs ES; Pett S; Weintrob AC; Chang CC; Murrary DD; Günthard HF; Moquete E; Grandits G; Engen N; Grund B; Sharma S; Cao H; Gupta R; Osei S; Margolis D; Zhu Q; Polizzotto MN; Babiker AG; Davey VJ; Kan V; Thompson BT; Gelijns AC; Neaton JD; Lane HC; Jundgren JD; Tierney J; Barrett K; Herpin BR; Smolskis MC; Voge SE; McNay LA; Cahill K; Crew P; Kirchoff M; Sardana R; Raim SS; Chiu J; Hensley L; Lorenzo J; Mock R; Shaw-Saliba K; Zuckerman J; Adam SJ; Currier J; Read S; Hughes E; Amos L; Carlsen A; Carter A; Davis B; Denning E; DuChene A; Harrison M; Kaiser P; Koopmeiners J; Meger S; Murray T; Quan K, 2022, 'Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial', Lancet Infectious Diseases, 22, pp. 622 - 635, http://dx.doi.org/10.1016/S1473-3099(21)00751-9
Polizzotto M; Nordwall J; Babiker AG; Phillips A; Vock DM; Eriobu N; Khwaghe V; Paredes R; Mateu L; Ramachandruni S; Narang R; Jain MK; Lazarte SM; Baker JV; Frosch AEP; Poulakou G; Syrigos KN; Arnoczy GS; McBride NA; Robinson PA; Sarafian F; Bhagani S; Taha HS; Benfield T; Liu STH; Antoniadou A; Jensen JUS; Kalomenidis I; Susilo A; Hariadi P; Jensen TO; Morales-Rull JL; Helleberg M; Meegada S; Johansen IS; Canario D; Fernández-Cruz E; Metallidis S; Shah A; Sakurai A; Koulouris N; Trotman R; Weintrob AC; Podlekareva D; Hadi U; Lloyd KM; Røge BT; Saito S; Sweerus K; Malin JJ; Lübbert C; Muñoz J; Cummings MJ; Losso MH; Turner D; Shaw-Saliba K; Highbarger H; Lallemand P; Rehman T; Dewar R; Gerry N; Arlinda D; Chang CC; Grund B; Holbrook M; Holley HP; Hudson F; McNay LA; Murray DD; Pett S; Shaughnessy M; Smolskis MC; Touloumi G; Wright M; Doyle MK; Popik S; Hall C; Ramanathan R; Cao H; Mondou E; Willis T; Thakuria JV; Yel L; Higgs E; Kan VL; Lundgren JD; Neaton JD; Lane HC; Amos L; Carlsen A; Carter A; Davis B; Denning E; DuChene A; Engen N; Grandits G; Harrison M; Kaiser P; Meger S; Murray T, 2022, 'Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial', Lancet, 399, pp. 530 - 540, http://dx.doi.org/10.1016/S0140-6736(22)00101-5
Murray DD; Babiker AG; Baker JV; Barkauskas CE; Brown SM; Chang CC; Davey VJ; Gelijns AC; Ginde AA; Grund B; Higgs E; Hudson F; Kan VL; Lane HC; Murray TA; Paredes R; Parmar MKB; Pett S; Phillips AN; Polizzotto MN; Reilly C; Sandkovsky U; Sharma S; Teitelbaum M; Thompson BT; Young BE; Neaton JD; Lundgren JD, 2022, 'Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)', Clinical Trials, 19, pp. 52 - 61, http://dx.doi.org/10.1177/17407745211049829
Hung RKY; Binns-Roemer E; Booth JW; Hilton R; Harber M; Santana-Suarez B; Campbell L; Fox J; Ustianowski A; Cosgrove C; Burns JE; Clarke A; Price DA; Chadwick D; Onyango D; Hamzah L; Bramham K; Sabin CA; Winkler CA; Post FA; GEN-AFRICA Study Group , 2022, 'Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV.', Kidney Int Rep, 7, pp. 786 - 796, http://dx.doi.org/10.1016/j.ekir.2022.01.1054
Hung RKY; Rosenberg K-L; David V; Binns-Roemer E; Booth JW; Hilton R; Fox J; Burns F; Ustianowski A; Cosgrove C; Hamzah L; Burns JE; Clarke A; Chadwick D; Price DA; Kegg S; Campbell L; Bramham K; Sabin CA; Post FA; Winkler CA; GEN-AFRICA Study Group , 2022, 'GSTM1 Copy Number and Kidney Disease in People With HIV.', Kidney Int Rep, 7, pp. 1901 - 1904, http://dx.doi.org/10.1016/j.ekir.2022.05.003
Burns JE; Stirrup O; Waters L; Dunn D; Gilson R; Pett SL, 2022, 'No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naïve adults.', HIV Med, 23, pp. 294 - 300, http://dx.doi.org/10.1111/hiv.13186
Grundmann A; Hardwick M; Wu C-H; Semple M; Böhning D; Pett S; Michael B; Thomas R; Galea I, 2022, 'Prevention of neurological complications during COVID-19: a retrospective analysis of the ISARIC4C national cohort', Journal of Neurology, Neurosurgery & Psychiatry, 93, pp. e2.135 - e2.135, http://dx.doi.org/10.1136/jnnp-2022-abn2.22
Hung RKY; Binns-Roemer E; Booth JW; Hilton R; Fox J; Burns F; Harber M; Ustianowski A; Hamzah L; Burns JE; Clarke A; Price DA; Kegg S; Onyango D; Santana-Suarez B; Campbell L; Bramham K; Sharpe CC; Sabin CA; Winkler CA; Post FA; GEN-AFRICA Study Group , 2022, 'Sickle Cell Trait and Kidney Disease in People of African Ancestry With HIV.', Kidney Int Rep, 7, pp. 465 - 473, http://dx.doi.org/10.1016/j.ekir.2021.12.007
Murray DD; Babiker AG; Baker J; Barkauskas CE; Brown SM; Chang CC; Davey VJ; Gelijns AC; Ginde AA; Grund B; Higgs E; Hudson F; Kan VL; Lane HC; Murray TA; Paredes R; Parmar MKB; Pett S; Phillips AN; Polizzotto MN; Reilly C; Sandkovsky U; Sharma S; Teitelbaum M; Thompson BT; Young BE; Neaton JD; Lundgren JD, 2021, 'Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)', CLINICAL TRIALS, 19, pp. 52 - 61, http://dx.doi.org/10.1177/17407745211049829
Hung R; Patel N; Fox J; Cosgrove C; Pett SL; Burns F; Ustianowski A; Rosenvinge M; Bhagani S; Dusheiko G; Childs K; Post FA; GEN-AFRICA study group , 2021, 'Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.', AIDS, 35, pp. 1701 - 1704, http://dx.doi.org/10.1097/QAD.0000000000002929
Cooke GS; Pett S; McCabe L; Jones C; Gilson R; Verma S; Ryder SD; Collier JD; Barclay ST; Ala A; Bhagani S; Nelson M; Ch'Ng C; Stone B; Wiselka M; Forton D; McPherson S; Halford R; Nguyen D; Smith D; Ansari A; Dennis E; Hudson F; Barnes EJ; Walker AS, 2021, 'Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C', Wellcome Open Research, 6, pp. 93 - 93, http://dx.doi.org/10.12688/wellcomeopenres.16594.2
Yang H; Llano A; Cedeño S; von Delft A; Corcuera A; Gillespie GM; Knox A; Leneghan DB; Frater J; Stöhr W; Fidler S; Mothe B; Mak J; Brander C; Ternette N; Dorrell L; Research in Viral Eradication of Reservoirs (RIVER) trial study group , 2021, 'Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses.', Cell Rep, 35, pp. 109103, http://dx.doi.org/10.1016/j.celrep.2021.109103
Pett SL; Spyer M; Haddow LJ; Nhema R; Benjamin LA; Najjuka G; Bilima S; Daud I; Musoro G; Kitabalwa J; Selemani G; Kandie S; Cornelius KM; Katemba C; Berkley JA; Hassan AS; Kityo C; Hakim J; Heyderman RS; Gibb DM; Walker AS, 2021, 'Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status', AIDS, 35, pp. 585 - 594, http://dx.doi.org/10.1097/QAD.0000000000002781
Butler M; Tamborska A; Wood GK; Ellul M; Thomas RH; Galea I; Pett S; Singh B; Solomon T; Pollak TA; Michael BD; Nicholson TR, 2021, 'Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder.', J Neurol Neurosurg Psychiatry, 92, pp. 1144 - 1151, http://dx.doi.org/10.1136/jnnp-2021-326924
Flower B; McCabe L; Le Ngoc C; Le Manh H; Le Thanh P; Dang Trong T; Vo Thi T; Vu Thi Kim H; Nguyen Tat T; Phan Thi Hong D; Nguyen Thi Chau A; Dinh Thi T; Tran Thi Tuyet N; Tarning J; Kingsley C; Kestelyn E; Pett SL; Thwaites G; Nguyen Van VC; Smith D; Barnes E; Ansari MA; Turner H; Rahman M; Walker AS; Day J; Cooke GS, 2021, 'High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis With 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH Study.', Open Forum Infect Dis, 8, pp. ofab267, http://dx.doi.org/10.1093/ofid/ofab267
Judd A; Collins IJ; Pett S; Gibb DM, 2021, 'Labour pains: eliminating HCV in women and children.', Lancet Gastroenterol Hepatol, 6, pp. 150 - 151, http://dx.doi.org/10.1016/S2468-1253(20)30373-3
Wendt CH; Castro-Pearson S; Proper J; Pett S; Griffin TJ; Kan V; Carbone J; Koulouris N; Reilly C; Neaton JD; INSIGHT FLU003 Plus Study Group , 2021, 'Metabolite profiles associated with disease progression in influenza infection.', PLoS One, 16, pp. e0247493, http://dx.doi.org/10.1371/journal.pone.0247493
Ray STJ; Abdel-Mannan O; Sa M; Fuller C; Wood GK; Pysden K; Yoong M; McCullagh H; Scott D; McMahon M; Thomas N; Taylor M; Illingworth M; McCrea N; Davies V; Whitehouse W; Zuberi S; Guthrie K; Wassmer E; Shah N; Baker MR; Tiwary S; Tan HJ; Varma U; Ram D; Avula S; Enright N; Hassell J; Ross Russell AL; Kumar R; Mulholland RE; Pett S; Galea I; Thomas RH; Lim M; Hacohen Y; Solomon T; Griffiths MJ; Michael BD; Kneen R; CoroNerve study group , 2021, 'Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study.', Lancet Child Adolesc Health, 5, pp. 631 - 641, http://dx.doi.org/10.1016/S2352-4642(21)00193-0
Alagaratnam J; Stöhr W; Toombs J; Heslegrave A; Zetterberg H; Gisslén M; Pett S; Nelson M; Clarke A; Nwokolo N; Johnson MA; Khan M; Hanke T; Kopycinski J; Dorrell L; Fox J; Kinloch S; Underwood J; Pace M; Frater J; Winston A; Fidler S; RIVER trial study group , 2021, 'No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach.', J Virus Erad, 7, pp. 100056, http://dx.doi.org/10.1016/j.jve.2021.100056
Back to profile page